Daniel Vasella - 2009 CEO Pay

Daniel Vasella, Novartis CEO

Daniel Vasella - Novartis

Total Compensation: $17.8 million

Details: In his last year as Novartis' chairman and chief executive, Vasella received a base salary of $2.6 million in 2009, plus short-term incentives of about $99,000, long-term incentives totaling $1.6 million and benefits of about $385,000. He owned 2,924,114 shares in the company. After 14 years as Novartis' CEO, Vasella announced he was stepping down in January. He was replaced by Novartis pharma chief Joe Jimenez (photo).

Novartis News:
Vasella, Jimenez share the limelight
Novartis chief steps aside for Jimenez
New Novartis chief talks productivity
Novartis CEO goes on a 'decluttering' drive
Falling Novartis stock deflates bid for Alcon shares

Daniel Vasella - 2009 CEO Pay

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.